On January 7, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that it will participate in an upcoming virtual investor conference (Press release, Delcath Systems, JAN 7, 2022, View Source [SID1234598404]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright BioConnect Virtual Investor Conference January 10-13, 2022
Presentation Date and Time: On-demand beginning January 10, 2022 at 7:00 AM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].